These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1475308)

  • 1. 2-Deoxy-D-glucose antinociception and serotonin receptor subtype antagonists: test-specific effects in rats.
    Fisher MC; Bodnar RJ
    Pharmacol Biochem Behav; 1992 Dec; 43(4):1241-6. PubMed ID: 1475308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naltrexone, serotonin receptor subtype antagonists, and glucoprivic intake: 1. 2-Deoxy-D-glucose.
    Beczkowska IW; Koch JE; Bodnar RJ
    Pharmacol Biochem Behav; 1992 Aug; 42(4):661-70. PubMed ID: 1513847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naltrexone, serotonin receptor subtype antagonists, and glucoprivic intake: 2. Insulin.
    Koch JE; Beczkowska IW; Bodnar RJ
    Pharmacol Biochem Behav; 1992 Aug; 42(4):671-80. PubMed ID: 1513848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naltrexone, serotonin receptor subtype antagonists, and carbohydrate intake in rats.
    Islam AK; Dougherty T; Koch JE; Bodnar RJ
    Pharmacol Biochem Behav; 1994 May; 48(1):193-201. PubMed ID: 8029291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of catecholaminergic and serotonergic receptor antagonists on the hyperglycaemic response to the neuroglucopaenic agent, 2-deoxy-D-glucose.
    Baudrie V; Chaouloff F
    Neuropharmacology; 1991 Jun; 30(6):599-605. PubMed ID: 1656302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naloxone and serotonin receptor subtype antagonists: interactive effects upon deprivation-induced intake.
    Beczkowska IW; Bodnar RJ
    Pharmacol Biochem Behav; 1991 Mar; 38(3):605-10. PubMed ID: 1906186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local infusion of the serotonin antagonists ritanserin or ICS 205,930 increases in vivo dopamine release in the rat medial prefrontal cortex.
    Pehek EA
    Synapse; 1996 Sep; 24(1):12-8. PubMed ID: 9046072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential actions of central alloxan upon opioid and nonopioid antinociception in rats: a further examination.
    Lubin E; Kest B; Bodnar RJ
    Brain Res Bull; 1991 Jul; 27(1):35-9. PubMed ID: 1933432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin receptor subtype antagonists in the medial ventral medulla inhibit mesencephalic opiate analgesia.
    Kiefel JM; Cooper ML; Bodnar RJ
    Brain Res; 1992 Dec; 597(2):331-8. PubMed ID: 1473004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that spinal 5-HT1, 5-HT2 and 5-HT3 receptor subtypes modulate responses to noxious colorectal distension in the rat.
    Danzebrink RM; Gebhart GF
    Brain Res; 1991 Jan; 538(1):64-75. PubMed ID: 2018933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin contributes to the spinal antinociceptive effects of morphine.
    Crisp T; Stafinsky JL; Uram M; Perni VC; Weaver MF; Spanos LJ
    Pharmacol Biochem Behav; 1991 Jul; 39(3):591-5. PubMed ID: 1686100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential influence of two serotonin 5-HT3 receptor antagonists on spinal serotonin-induced analgesia in rats.
    Bardin L; Jourdan D; Alloui A; Lavarenne J; Eschalier A
    Brain Res; 1997 Aug; 765(2):267-72. PubMed ID: 9313899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of 5-HT3 and cholinergic mechanisms in improgan antinociception.
    Nalwalk JW; Svokos K; Leurs R; Hough LB
    Pharmacol Biochem Behav; 2005 Mar; 80(3):505-10. PubMed ID: 15740793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal pharmacology of antinociception produced by microinjection of mu or delta opioid receptor agonists in the ventromedial medulla of the rat.
    Hurley RW; Banfor P; Hammond DL
    Neuroscience; 2003; 118(3):789-96. PubMed ID: 12710986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p-Chloroamphetamine, a serotonin-releasing drug, elicited in rats a hyperglycemia mediated by the 5-HT1A and 5-HT2B/2C receptors.
    Yamada J; Sugimoto Y; Yoshikawa T
    Eur J Pharmacol; 1998 Oct; 359(2-3):185-90. PubMed ID: 9832390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 5-HT receptor antagonists on morphine-induced tolerance in mice.
    Zarrindast MR; Sajedian M; Rezayat M; Ghazi-Khansari M
    Eur J Pharmacol; 1995 Feb; 273(3):203-7. PubMed ID: 7737326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the 5-HT2 receptor in the methamphetamine-induced neurochemical alterations.
    Johnson M; Sonsalla PK; Letter AA; Hanson GR; Gibb JW
    J Pharmacol Exp Ther; 1994 Jul; 270(1):97-103. PubMed ID: 7913500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathecal methysergide antagonizes the antinociception, but not the hyperalgesia produced by microinjection of baclofen in the ventromedial medulla of the rat.
    Hammond DL; Nelson V; Thomas DA
    Neurosci Lett; 1998 Mar; 244(2):93-6. PubMed ID: 9572593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of acute selective 5-HT1, 5-HT2, 5-HT3 receptor and alpha 2 adrenoceptor blockade on naloxone-induced antinociception.
    Walker MJ; Poulos CX; Le AD
    Psychopharmacology (Berl); 1994 Jan; 113(3-4):527-33. PubMed ID: 7862870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of benzodiazepine and serotonergic mechanisms in conditioned freezing and antinociception using electrical stimulation of the dorsal periaqueductal gray as unconditioned stimulus in rats.
    Castilho VM; Macedo CE; Brandão ML
    Psychopharmacology (Berl); 2002 Dec; 165(1):77-85. PubMed ID: 12474121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.